Hydrogenated Castor Oil Research Articles

Quartz crystal microbalance analysis of effects of surfactants on dissolution kinetics of poly(4-hydroxystyrene) partially protected with t-butoxycarbonyl group

Abstract Surfactants comprise water-repellent and water-attracting moieties and have been used to improve the lithographic performance of resist materials. However, the effects of surfactants on the dissolution kinetics of these materials are still unclear. In this study, the effects of surfactants on the dissolution kinetics of partially-protected poly(4-hydroxystyrene) (PHS) in 0.26 N tetramethylammonium hydroxide aqueous solution was investigated using a quartz crystal microbalance method. Anionic (sodium n-octanonate, sodium 1-hexanesulfonate, n-dodecylbenzenesulfonic acid, and sodium n-dodecyl sulfate), cationic (methylamine hydrochloride, dodecyltrimethylammonium chloride, and 30% ammonium lauryl sulfate solution), nonionic (sorbitan monooleate, polyoxyethylene(23)lauryl ether, and polyoxyethylene(10)hydrogenated castor oil), and amphoteric (35% lauryl dimethylaminoacetic acid solution) surfactants were examined. The surfactant significantly affected the dissolution kinetics of the PHS films. The surfactant effects were significantly reduced by protecting the hydroxyl groups of PHS. The effect of the surfactant on the dissolution kinetics depended on the surfactant rather than on the surfactant type.

Stable Porous Organic Cage Nanocapsules for pH-Responsive Anticancer Drug Delivery for Precise Tumor Therapy.

The search for drug nanocarriers with stimuli-responsive properties and high payloads for targeted drug delivery and precision medicine is currently a focal point of biomedical research, but this endeavor still encounters various challenges. Herein, a porous organic cage (POC) is applied to paclitaxel (PTX) drug delivery for cancer therapy for the first time. Specifically, water-soluble, stable, and biocompatible POC-based nanocapsules (PTX@POC@RH40) with PTX encapsulation efficiency over 98% can be synthesized by simply grafting nonionic surfactant (Polyoxyl 40 hydrogenated castor oil, RH40) on the POC surface. These PTX@POC@RH40 nanocapsules demonstrate remarkable stability for more than a week without aggregation and exhibit pH-responsive behavior under acidic conditions (pH 5.5) and display sustained release behavior at both pH 7.4 and pH 5.5. Intravenous administration of PTX@POC@RH40 led to a 3.5-fold increase in PTX bioavailability compared with the free PTX group in rats. Moreover, in vivo mouse model experiments involving 4T1 subcutaneous breast cancer tumors revealed that PTX@POC@RH40 exhibited enhanced anticancer efficacy with minimal toxicity compared with free PTX. These findings underscore the potential of POCs as promising nanocarriers for stimuli-responsive drug delivery in therapeutic applications.

Antinociceptive activity of transdermal nanostructured surfactant-based systems containing duloxetine hydrochloride

Duloxetine hydrochloride (DLX) is a serotonin and norepinephrine reuptake inhibitor that is effective in the treatment of chronic pain. However, the drug has several adverse reactions and extensive hepatic first-pass effect. This study aimed at developing surfactant-based formulations such as liquid crystals (LCs) and evaluating the influence of the formulations on DLX skin permeation and in vivo antinociceptive activity. Thereafter, the formulations were obtained using PEG-40 Hydrogenated Castor Oil, Tween 80, licuri oil and water. The systems selected showed isotropy, high viscosity and rheology suggestive of LCs. The systems presented ability to permeate DLX through the skin. ATR-FTIR demonstrated that formulations promoted lipid disorganization and modification of protein conformation, facilitating the drug diffusion through the stratum corneum. Moreover, the formulation loaded with DLX showed high antinociceptive activity in mice (tests of acetic acid-induced abdominal writhing, formalin and tail immersion) via the transdermal route. The antinociceptive activity was close to that of morphine (i.p.). In conclusion, the LC obtained proved to be a promising system for transdermal delivery of DLX and pain management.

A controlled release antibiotic wound protectant gel formulated for use in austere environments.

Battlefield wounds are at high risk of infection due to gross contamination and delays in evacuation from forward-deployed locations. The aim of this study was to formulate an antibiotic wound gel for application by a field medic in austere environments to protect traumatic wounds from infection during transport. Formulation development was conducted over multiple phases to meet temperature, handling, in vitro elution, and in vivo tissue response requirements. Thermal properties were evaluated by vial inversion, DSC, and syringe expression force in a temperature range of 4-49°C. Handling was evaluated by spreading onto blood-contaminated tissue and irrigation resistance. Controlled antibiotic release was evaluated by a modified USP immersion cell dissolution method. Local tissue effects were evaluated in vivo by subcutaneous implantation in rats for 7 and 28 days. An oleogel composition of cholesterol, hydrogenated castor oil, soybean oil, and glyceryl monocaprylocaprate met the target performance criteria. Peak expression force from a 5 mL syringe at 4°C was 48.3 N, the dropping point temperature was 68°C, and the oleogel formulation could be spread onto blood-contaminated tissue and resisted aqueous irrigation. The formulation demonstrated sustained release of tobramycin in PBS at 32°C for 5 days. Implantation in a rat dorsal pocket demonstrated a slight tissue reaction after 7 days with minimal to no reaction after 28 days, comparable to a commercial hemostat control. Material resorption was evident after 28 days. The formulation met target characteristics and is appropriate for further evaluation in a large animal contaminated blast wound model.

LabrafacTM MC60 is an efficacious intestinal permeation enhancer for macromolecules: Comparisons with Labrasol® ALF in ex vivo and in vivo rat studies

Labrafac™ MC60 (glycerol monocaprylocaprate) is a lipid-based excipient used in oral formulations as a solubiliser. Due to the high proportions of established permeability enhancers, caprylate (C8) and caprate (C10), in Labrafac™ MC60, we hypothesised that it might behave as an intestinal permeation enhancer. We therefore evaluated this using two paracellular markers (ex vivo) and insulin (in vivo) as model molecules. Ex vivo studies were conducted in isolated muscle-stripped rat colonic mucosae mounted in Ussing chambers. Apical addition of Labrafac™ MC60 (8, 12, and 16 mg/ml) enhanced the apparent permeability coefficients (Papp) of [14C] mannitol and FITC-dextran 4 kDa (FD4) across colonic mucosae. Similar effects were observed in isolated jejunal mucosae, but at higher concentrations (40 mg/ml). The enhancing capacity of Labrafac™ MC60 was transient due to reversibility of reductions in transepithelial electrical resistance (TEER) upon wash-out and effects on fluxes were molecular weight-dependent (MW) as suggested by fluxes of a set of high MW FITC-dextrans. The permeability enhancing effects of Labrafac™ MC60 ex vivo were maintained in the presence of simulated intestinal fluids, FaSSIF and FaSSCoF, in both jejunal and colonic mucosae, respectively. Following intra-intestinal regional instillations to rats, the relative bioavailability of 50 IU/kg insulin ad-mixed with Labrafac™ MC60 was 5 % in jejunum (40 mg/ml) and 6 % in colon (8 mg/ml). When Labrafac™ MC60 was combined with PEG-60 hydrogenated castor oil (1 % v/v), this further increased the bioavailability of insulin to 8 % in jejunum. Absorption enhancement was also maintained in the presence of FaSSIF in jejunal instillations. Histology after 120 min exposure to Labrafac™ MC60 in vivo for both jejunum and colon was similar to untreated control. Labrafac™ MC60 therefore acts as a non-damaging intestinal permeation enhancer for macromolecules and can be considered as another excipient in screening programmes to develop orally administered macromolecules.

Preparation of Rubra (Paeonia lactiflora Pall.) extract and studies in activity and skin penetration

The inhibition rate of tyrosinase activity was used to determine extraction solvent of Paeoniae Radix Rubra extract (PRRE), which was established quality control standards by HPLC and verified the antioxidant activity. Ternary phase diagram was used to screen the best formulation of PRRE nanoemulsion, the skin permeability of PRRE and nanoemulsion were compared. The results show that 70% ethanol as the extraction solvent were highest (88.89%) and the contents of catechin (CC) and paeoniflorin (PF) in PRRE were 0.145 ± 0.0006 μg/mg and 21.783 ± 0.0247 μg/mg, respectively. The inhibition rate of PRRE on pyrogallol autoxidation was 6.94% ± 0.53%. The optimal formulation is Isopropyl myristate (IPM) as oil phase, Ethoxylated hydrogenated castor oil (RH40) as emulsifier, glycerine as coemulsifier, Km 3:1. The skin penetration of CC in PRRE nanoemulsion (0.79 ± 0.04 μg·cm−2) was significantly higher than that PRRE (0.17 ± 0.09 μg·cm−2) after 12 h.

Formulation and Evaluation of Taste Masked Chewable Tablet containing Curcumin, Acetaminophen, and Ascorbic acid to treat sore throat

Objective: This study was intended to investigate the formulation and characterization of Mesalamine or 5-Aminosalicylic acid (5-ASA) pellets using novel excipient and formulated as matrix spheres to controlled the drug release extended period of time. Uniformly distributed throughout the gastrointestinal tract and Avoid dose dumping of drug. Methods: Mesalamine's active pharmaceutical component was characterised, and investigations were conducted prior to formulation to ensure a physical combination of the drug and excipients was achieved. Formulation of mesalamine as matrix pellets by using fluid bed processor and mesalamine loaded into seal coated sugar spheres and extended-release coating with Ethyl cellulose. Ethyl cellulose is pH independent polymer and retarder the drug release throughout the gastrointestinal tract and site-specific action in colon. Hypromellose also act as pore former and drug release based on diffusion mechanism. In drug layering, core pellets contain stearic acid and hydrogenated castor oil internally forming a matrix. Developed mesalamine pellets are characterized such as drug content, invitro drug release and appearances and particle size distribution. Results: Development of Mesalamine pellets based on five strategy From MEZ 1 to MEZ 5 are formulated and Characterization are performed. Based on the invitro drug release studies, we concluded that the formulation MEZ-IV was best formulation. Invitro drug release is consistence throughout 12hours.(1hrs-23%, 2nd hrs 41%, 4hrs-73, 6hrs-86, 8hrs-99% and 12hrs-10.

Cosmetic degradation: A study on body lotions with botanical extracts

Lipid oxidation is a spontaneous process in fats and, consequently, in products with significant fat content. Many cosmetics fall into this category, presenting an intrinsic relationship between the productʼs quality, oxidation capacity, and market value. This study comprehensively investigated the aging of body lotions, accentuating the role of their chemical formulations. Sensory analysis clarified that controlled temperature-induced aging significantly altered the lotions' appearance, texture, color, and, to a lesser extent, odor, hinting at the onset of rancidity. As lipid peroxidation unfolds, the emergence of secondary oxidation products like aldehydes, ketones, and alcohols becomes prominent. These secondary products indicate a potential degradation in the lotion's quality and efficacy. Quantifying the primary oxidation products was possible using methods like the quantification of Conjugated Dienes (CD) expressed in percentage and the Peroxide Index (PI) method expressed in meqO2/kg of a dry sample. On the other hand, methods such as the p-Anidisine Index (pAi) and the thiobarbituric acid reactive substances (TBARS) with malonaldehyde (MDA) expressed as malonaldehyde concentration (mg/g of dry sample) provided the quantification of secondary oxidation products. Regarding lipid oxidation, lotions containing sunflower and soybean oils emerged as notably susceptible. Conversely, samples that demonstrated minimal oxidation, were attributed to protective elements such as Aloe barbadensis and Calendula officinalis extracts. Examining into secondary oxidation, four samples displayed the highest TOTOX values, indicating extensive oxidation. A discernible correlation was observed between TOTOX values and natural extracts' presence (or lack), underscoring their protective or exacerbating roles. Certain natural ingredients, including A. barbadensis leaf juice powder and C. officinalis flower extract, were recognized as supporters against oxidation. Yet, components like PEG-40 hydrogenated castor oil can, paradoxically, seem to intensify the oxidative cascade. This research provides crucial insights into the interplay between natural extracts and lipid oxidation in body lotions. The elucidated results accentuate the necessity for judicious ingredient selection, balancing the inclusion of natural extracts to ensure product quality, longevity, and safety.

Determination of stearic acid and 12-hydroxyoctadecanoic acid in PEG-60 hydrogenated castor oil by HPLC-ELSD after alkaline hydrolysis

AbstractA rapid and simple method for the determination of stearic acid and 12-hydroxystearic acid in PEG-60 hydrogenated castor oil by high performance liquid chromatography with evaporative light scattering detection was established. The oil sample was first pretreated by alkaline hydrolysis. The analysis was performed on a Zhongpu Develop XD-C18 column (250 mm × 4.6 mm, 5 µm) with gradient elution of methanol and 1% acetic acid aqueous solution at a flow rate of 1.2 mL·min−1 and a column temperature of 40 °C. The drift tube temperature of the evaporative light scattering detection system was set at 40 °C, and the pressure of carrier gas (N2) was 337 kPa. The regression equation revealed a good linear relation (r = 0.9993–0.9995) during the test ranges (119.1–1190.7 μg·mL−1 for 12-hydroxystearic acid, 10.7–107.4 μg·mL−1 for stearic acid). The detection limits of 12-hydroxystearic acid and stearic acid were 1.1 and 2.5 μg·mL−1, the limits of quantitation were 3.2 and 7.4 μg·mL−1, respectively. And the mean recoveries were 101.5 and 101.0%, the corresponding relative standard deviations (RSDs) were 2.1 and 2.8%, respectively. The RSDs corresponding to repeatability (n = 6) were both less than 1.7% in terms of precision. As to the stability, the test results remained stable after 8 h at room temperature (RSDs were both less than 2.6%). The developed method showed high sensitivity, recovery, repeatability and stability, which indicated that the method could be applied as a quality evaluation method for the determination of stearic acid and 12-hydroxyoctadecanoic acid in PEG-60 hydrogenated castor oil.

Development of an emulsion composition with fennel and caraway essential oils for use in the combined therapy of ulcerative colitis

The aim of the study is to develop the composition of an emulsion containing essential oils of Fennel and Caraway seeds for use in the symptomatic complex therapy of ulcerative colitis with the aim of eliminating functional intestinal disorders. Materials and methods. The objects of the study were samples of emulsions containing active pharmaceutical ingredients (essential oils of Fennel and Caraway), purified water, oils (refined sunflower oil, refined olive oil, refined sesame oil), emulsifiers (polyethylene glycol 40 hydrogenated castor oil, polysorbate 80, polyethylene glycol 100 stearate, acacia gum, guar gum, xanthan gum, soya lecithin), viscosity regulator - apple pectin and flavouring agents (food additives with cherry and tarragon flavour). Organoleptic properties, stability, rheological parameters, pH, particle size determination by microscopy, and a taste test were carried out with model emulsion samples. Research to establish the optimal technological parameters was carried out in parallel. Results. The main parameters of the technological process have been established, which allow to obtain an emulsion with evenly distributed particles: 15 minutes at maximum speed. The concentration of emulsifiers at which the emulsions are stable was selected. It was found that the samples containing polyethylene glycol 100 stearate, gums, and soy lecithin have satisfactory organoleptic properties. The sample with soy lecithin emulsifier differs from the others in its ability to form microemulsions, but it has low viscosity. To improve the rheological properties, apple pectin was added to the emulsion. The taste test showed that among vegetable oils, refined sesame oil has a more neutral taste, and the flavouring additive "Tarkhun" balances the taste better. The release of active pharmaceutical ingredients (APIs) from the emulsion base was confirmed by thin-layer chromatography. Conclusions. A microemulsion with essential oils based on refined sesame oil, soy lecithin, with the addition of viscosity and flavour correctors was developed. The obtained emulsion has satisfactory organoleptic properties and conforms to the requirements for emulsion quality indicators

Formulation of Microemulsion-based Gel Containing Mango Seed Kernel Extract for Application in Anti-inflammation

Published research showed that mango seeds have good anti-inflammatory and antibacterial properties. The purpose of this study is to develop a microemulsion formula containing mango seed extract for application in the treatment of inflammatory acne. Isopropyl myristate and coconut oil were selected as the fixed oil phase components. Phase diagrams for the microemulsion regions were constructed using PEG 40 hydrogenated castor oil as surfactant and PEG 400 as co-solvent. Microemulsions were prepared by titration and mixed with mango seed extract. Microemulsions and the physical and chemical stability of the microemulsion were evaluated for droplet size and PDi index using dynamic light scattering techniques. The microemulsion was gelled and evaluated for its anti-inflammatory effect by comparing it with an acne cream on the market. The selected microemulsion formula has a ratio of isopropyl myristate oil to coconut oil of 1:2, Smix/Co is PEG 40 hydrogenated castor oil to PEG 400 with a ratio of 3:1, and a high loading efficiency of 5% mango seed. The average particle size of the microemulsion reached 22.74 nm. The selected microemulsion showed good stability, with almost no change in particle size when stored at room temperature after 30 days. The microemulsion was gelled with 7% carbopol, and the permeability of polyphenols from the microemulsion gel within 6 hours was observed to be about 59.61%. The microemulsion gel inhibited the denaturation of bovine serum albumin, indicating that the microemulsion containing coconut oil and mango extract may help in treating inflammatory acne. Microemulsion gel containing mango seed kernel has been successfully studied, has anti-inflammatory activity equivalent to a modern control drug, and is promising as a natural preparation that can provide anti-inflammatory protection on acne skin. However, further clinical studies need to be conducted before use.

The substantiation of the composition and technology of obtaining a microemulsion in laboratory conditions for pediatric use

Aim. To substantiate the composition and parameters of the technological process of obtaining a microemulsion with the essential oil of common fennel fruit for pediatric use. Materials and methods. The study objects were experimental samples of an emulsion with fennel essential oil (active pharmaceutical ingredient), acacia, xanthan and guar gums, soy lecithin, PEG-40 hydrogenated castor oil, PEG-100 stearate, glycerin monostearate, polysorbate-80 (emulsifiers) and purified water. Information-search, information-analytical, organoleptic, physicochemical, rheological and pharmacotechnological research methods were used. The rheological parameters were determined on a “Reotest-2” rotary viscometer (Germany) with coaxial cylinders, pH was measured potentiometrically on a pH‒150 MI pH-meter (Khimtest Ukraine+), thermal stability was determined in a SP50 drying cabinet. The microscopic studies of experimental emulsion samples were carried out using a Granum microscope with a Toupcam UCMOS video camera. The statistical processing of the data obtained was performed using Microsoft Excel 2007 spreadsheets. Results and discussion. The composition and technology of obtaining a microemulsion with the essential oil of fennel fruit in the conditions of a pharmacy for pediatric use were experimentally substantiated. The technological process consisted of the following stages: preparatory work, weighing of ingredients, mixing of ingredients, packaging, and registration of the drug for dispensing. The drug was manufactured in aseptic conditions. Standardization of the drug obtained was carried out: description, thermal and colloidal stability, pH value, viscosity, uniformity of the mass of doses extracted from multi-dose containers, mass of the contents of the container. The presence of anethole and terpenoids was proven by TLC method. Conclusions. At the current level of development of the pharmaceutical industry, the improvement of providing consumers with high-quality medicines is implemented by choosing the optimal dosage form, the composition of excipients, rational technology, and the use of modern equipment.

Design of High-Payload Ascorbyl Palmitate Nanosuspensions for Enhanced Skin Delivery.

A high-payload ascorbyl palmitate (AP) nanosuspension (NS) was designed to improve skin delivery following topical application. The AP-loaded NS systems were prepared using the bead-milling technique, and softly thickened into NS-loaded gel (NS-G) using hydrophilic polymers. The optimized NS-G system consisted of up to 75 mg/mL of AP, 0.5% w/v of polyoxyl-40 hydrogenated castor oil (Kolliphor® RH40) as the suspending agent, and 1.0% w/v of sodium carboxymethyl cellulose (Na.CMC 700 K) as the thickening agent, in citrate buffer (pH 4.5). The NS-G system was embodied as follows: long and flaky nanocrystals, 493.2 nm in size, -48.7 mV in zeta potential, and 2.3 cP of viscosity with a shear rate of 100 s-1. Both NS and NS-G provided rapid dissolution of the poorly water-soluble antioxidant, which was comparable to that of the microemulsion gel (ME-G) containing AP in solubilized form. In an ex vivo skin absorption study using the Franz diffusion cell mounted on porcine skin, NS-G exhibited faster absorption in skin, providing approximately 4, 3, and 1.4 times larger accumulation than that of ME-G at 3, 6, and 12 h, respectively. Therefore, the high-payload NS makes it a promising platform for skin delivery of the lipid derivative of ascorbic acid.

Conducting biological tests in the development of self-emulsifying drug delivery systems with simvastatin

The aim of the study was to compare the hypolipidemic activity of the developed self-emulsifying drug delivery systems with simvastatin with reference samples of the substance and the finished drug product of industrial production. Materials and methods. The substance of simvastatin (India, s. DK40-2005021, 99.09 %, introduced into the composition of self-emulsifying compositions based on castor oil (Ukraine), polyethylene glycol 40 hydrogenated castor oil (India), Tween 80 (Ukraine), glycerol monostearate (Gustav Heess GmbH, Germany) or polyethylene glycol 100 stearate (ERCA, Italy). Reference samples were Simvastatin-Sandoz (Salutas Pharma, Germany, series LX5161) and simvastatin in pure form. The experimental animals were Syrian hamsters aged 2 months. Hyperlipidemia was modeled by means of an alimentary load. To assess the state of lipid metabolism in animals, the content of triacylglycerols, total cholesterol, low-density lipoprotein and high-density lipoprotein in the blood serum was determined by colorimetric enzymatic methods using the appropriate standard reagent kits "Triacylglycerols F" HP022.02, "Cholesterol F" HP026.02, "Cholesterol-LDL F" HP026.05 and "Cholesterol-HDL F" HP026.04 (LLC SPE "Filicit-Diagnostics", Ukraine) on a semi-automatic biochemical analyzer MapLab Plus (BSI, Italy). Results. The reference samples had similar dose-dependent efficacy parameters. At the same time, the test samples, also having similar dose-dependent effects, in absolute terms at the maximum concentration reduced the amount of low-density lipoprotein and total cholesterol more effectively than the reference samples. When using the test samples in their average concentration, the level of triglycerols was significantly reduced, which is rather a concomitant effect of simvastatin. Conclusions. The improvement of the overall efficacy of simvastatin when it is introduced into self-emulsifying drug delivery systems has been proved, which is associated with the modification of pharmacokinetic parameters by improving the solubility of the substance in the aqueous environment of the gastrointestinal tract

Cutaneous anaphylactoid reaction to polyoxyethylene hydrogenated castor oil in dogs.

Polyoxyethylene hydrogenated castor oil (HCO ethoxylates) is a nonionic surfactant used as an excipient for ointments and injections in human and veterinary drugs. Several polyethylene glycol (PEG) derivatives can be obtained depending on the number of moles of ethylene oxide (EO). HCO ethoxylates have the potential to cause anaphylactoid reactions. There is little published information about these types of reactions in dogs. To determine the potential for HCO-ethoxylate-containing drugs to cause anaphylactoid reactions in dogs, employing intradermal testing (IDT) with various concentrations of HCO ethoxylates (HCO-25, -40, -60 and -80). Four healthy male laboratory dogs. We performed IDT with drugs containing HCO ethoxylates and HCO ethoxylates alone to determine threshold concentrations. The IDT scores and threshold concentrations were compared. Analysis of skin biopsies from IDT sites was used to measure the percentage of degranulated mast cells. The effect of histamine at IDT sites was investigated by pre-treatment with an antihistamine. All HCO-ethoxylate-containing drugs caused a wheal-and-flare reaction. The threshold concentrations (0.001% and 0.00001%) of each HCO-ethoxylate depended on the number of moles of EO (p < 0.05). Mast cell degranulation was enhanced by all HCO ethoxylates. The HCO-60-induced reaction was suppressed by an oral antihistamine. The threshold concentration can serve as a consideration for developing safe new drug formulations and for clinical decision-making around using drugs containing PEG derivatives. IDT is useful to predict the risk of adverse effects. Antihistamines could demonstrate a prophylactic effect.

Stable nanoemulsions for poorly soluble curcumin: From production to digestion response in vitro

Curcumin, a polyphenol, can induce anticancer activity depending on dose. However, oral curcumin administration is limited by its low bioavailability due to aqueous insolubility and instability against physiological conditions. This study aims at formulating nanoemulsions by phase inversion temperature to enhance curcumin loading, stability, antioxidant performance, bioaccessibility, and in vitro absorption. The selection mechanisms for oil phase (coconut oil), surfactant (polyoxyl 40 hydrogenated castor oil), co-surfactant (soy phospholipid), and aqueous phase (2 % wt citrate buffer at pH 4.5) are established. The nanoemulsions show tunable mean droplet size (26–129 nm), high curcumin loading (9.53 ± 0.49 mg/mL), polydispersity < 0.3, and ζ-potential < -26 mV. Nanoencapsulation increases curcumin photostability by 36–42 % and the antioxidant activity after 24-hour UV radiation is unchanged (P > 0.05). The curcumin nanoemulsions show ∼ 11 %, 24 %, and 57 % higher retention and ∼ 10 %, 12 %, and 17 % higher antioxidant activity than raw curcumin after 3-hour simulated gastric, intestinal, and physiological incubations, respectively. During in vitro digestion and absorption, the encapsulated curcumin shows higher bioaccessibility and absorption than free curcumin (P < 0.05). The samples are stable during 4-week storage at 4˚C and room temperature without preservatives. These findings suggest the potential to develop a nanoencapsulation strategy, particularly for an oral delivery system of oil-soluble drugs.

Techno-economic analysis of Castor (Ricinus communis) Oil Refinery Process Simulation

Castor (Ricinus communis) plants have been cultivated. Castor oil has been cultivated and has become one of the world’s major commodities, with the leading producer being India. Castor oil’s primary products and derivatives include Hydrogenated Castor Oil (HCO), polymers, lubricants, and biodiesel. Conventional extraction is usually done using a machine or hot water extraction methods. In large industries, extraction is carried out to obtain high purity with the help of solvents. Organic solvents are suitable for extraction, such as methanol, ethanol, and n-hexane, which are the most commonly used. This research aims to obtain techno-economic feasibility through a simulation of castor oil production using SuperPro Designer version 13.0. The extraction process is carried out in two stages: mechanical extraction followed by water degumming, neutralization, and adsorption with activated carbon. Production capacity and technology used are adjusted to existing companies and literature. From the results of the economic analysis, this production process is feasible with an IRR of 32.11%, a PBP of 3.25 years, and a BC Ratio of 1.05.

Curcumin-Loaded RH60/F127 Mixed Micelles: Characterization, Biopharmaceutical Characters and Anti-Inflammatory Modulation of Airway Inflammation.

Curcumin's ability to impact chronic inflammatory conditions, such as metabolic syndrome and arthritis, has been widely researched; however, its poor bioavailability limits its clinical application. The present study is focused on the development of curcumin-loaded polymeric nanomicelles as a drug delivery system with anti-inflammatory effects. Curcumin was loaded in PEG-60 hydrogenated castor oil and puronic F127 mixed nanomicelles (Cur-RH60/F127-MMs). Cur-RH60/F127-MMs was prepared using the thin film dispersion method. The morphology and releasing characteristics of nanomicelles were evaluated. The uptake and permeability of Cur-RH60/F127-MMs were investigated using RAW264.7 and Caco-2 cells, and their bioavailability and in vivo/vitro anti-inflammatory activity were also evaluated. The results showed that Cur-RH60/F127-MMs have regular sphericity, possess an average diameter smaller than 20 nm, and high encapsulation efficiency for curcumin (89.43%). Cur-RH60/F127-MMs significantly increased the cumulative release of curcumin in vitro and uptake by cells (p < 0.01). The oral bioavailability of Cur-RH60/F127-MMs was much higher than that of curcumin-active pharmaceutical ingredients (Cur-API) (about 9.24-fold). The treatment of cell lines with Cur-RH60/F127-MMs exerted a significantly stronger anti-inflammatory effect compared to Cur-API. In addition, Cur-RH60/F127-MMs significantly reduced OVA-induced airway hyperresponsiveness and inflammation in an in vivo experimental asthma model. In conclusion, this study reveals the possibility of formulating a new drug delivery system for curcumin, in particular nanosized micellar aqueous dispersion, which could be considered a perspective platform for the application of curcumin in inflammatory diseases of the airways.

Preparation and performance characterization of temperature‐sensitive JP‐3 kerosene gel propellant

AbstractTwo types of JP‐3 kerosene gels were prepared using AC−C10 (N‐acetyl‐L‐isoleucyl decylamine, type A) and modified hydrogenated castor oil (type B) as gelling agents, and the gel formation mechanism between the two gelling agents and JP‐3 kerosene was investigated. The rheological properties of the gels, including stability, yield stress, shear thinning, and thixotropic behavior, were tested and discussed. The viscosity curves were fitted with the HBE constitutive equation and compared with the power‐law model. Non‐time‐dependent, time‐dependent, and temperature‐dependent constitutive equations of the kerosene gels were constructed. The effects of time and temperature on viscosity were analyzed. The results showed that the type B JP‐3 kerosene gel was more physically stable and less influenced by centrifugal force. Both types of gels exhibited a decrease in viscosity with increasing shear rate, indicating shear thinning behavior. Additionally, both gels demonstrated some degree of thixotropy, although the recoagulation was found to be weak. With an increase in temperature, the viscosity of the type A gel initially decreased, then increased, and finally decreased again until it approached the viscosity of kerosene at 75 °C. On the other hand, the viscosity of the type B kerosene gel gradually decreased and approached the viscosity of kerosene at 75 °C. Both types of gels exhibited high temperature sensitivity.

Enhancing stability and antimicrobial activity of spearmint essential oil nanoemulsion through formulation optimization by mixture experimental design and in vitro drug release study

Spearmint essential oil (SEO) has been widely recognized for its therapeutic properties in treating gastrointestinal, respiratory, carminative, diuretic, antispasmodic, and sedative ailments. Moreover, it is commonly utilized as a flavoring agent in various food and beverage products. However, the effectiveness of SEO for medicinal purposes is hindered by its limited water solubility. Hence, the objective of this research was to determine the optimal conditions for producing a nanoemulsion of SEO by measuring turbidity through a mixture experimental design. The study aimed to investigate the impact of different formulation variables on turbidity as the response variable. These variables included PEG-40 hydrogenated castor oil (HCO) (1%–2% w/w), Tween 80 (1%–3% w/w), Tween 20 (1%–3% w/w), propylene glycol (PG) (5%–20% w/w), and polyethylene glycol 400 (5%–20% w/w). The results of the experimental design showed that the obtained data could be adequately fitted in a second-order polynomial model for the prediction of nanoemulsion turbidity with a multiple regression coefficient of 0.9704. The particle size value at the optimum condition was 81.28 nm, which was matched with the result of transmission electron microscopy (TEM). The thermodynamic and long-term stability of the prepared nanoemulsion were investigated. Furthermore, the developed nanoemulsion exhibited better antimicrobial activity against E. coli. In vitro release testing showed that the release of the optimized nanoemulsion was significantly increased. This study demonstrated that SEO is capable of forming stable nanoemulsions for use in delivery systems of flavoring agents in the food industry.